CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling
- 30 September 2008
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 122 (3), 617-624.e6
- https://doi.org/10.1016/j.jaci.2008.05.048
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Transforming Growth Factor-β1 Suppresses Airway Hyperresponsiveness in Allergic Airway DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependentThe Journal of Experimental Medicine, 2005
- Effective treatment of collagen‐induced arthritis by adoptive transfer of CD25+ regulatory T cellsArthritis & Rheumatism, 2005
- Airway wall remodelling: the influence of corticosteroidsCurrent Opinion in Allergy and Clinical Immunology, 2005
- Psychometric properties of the PTSD checklist—civilian versionJournal of Traumatic Stress, 2003
- Relationships among trauma exposure, chronic posttraumatic stress disorder symptoms, and self‐reported health in women: Replication and extensionJournal of Traumatic Stress, 2000
- Psychometric properties of the PTSD checklist (PCL)Behaviour Research and Therapy, 1996
- A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.The Journal of Experimental Medicine, 1996
- Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.The Journal of Experimental Medicine, 1996
- Diagnostic and Statistical Manual of Mental DisordersAlzheimer Disease & Associated Disorders, 1988